Concepedia
Statistics
Publications
34
Citations
1.5K
H-Index
23
Active since
2011
Affiliations
University of Parma(Current)
Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro
University of Bologna
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
University of Pisa
Roberta Minari is an author at University of Parma specializing in medicine, lung cancer, and oncology.
Top concepts
MedicineOncologyLung CancerPathologyPharmacologyCell BiologyTumor BiologyRadiation OncologyImmunologyImmunotherapy
Publications per year
2011–2024
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR -Mutated NSCLC
Melissa Bersanelli, Roberta Minari, Paola Bordi et al. · Journal of Thoracic Oncology · 2016 · 166 citations · Full text
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients
Giulia Mazzaschi, Roberta Minari, Alessandra Zecca et al. · Lung Cancer · 2020 · 114 citations
Cancer Immunosurveillance, Autoimmune Disease, Allergy +11
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
Roberta Minari, Paola Bordi, Marzia Del Re et al. · Lung Cancer · 2017 · 106 citations
Medicine, Sclc Transformation, T790m Determination +5
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
Silvia La Monica, Daniele Cretella, Mara Bonelli et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 89 citations · Full text
L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib
Donatella Callegari, Kara E. Ranaghan, Christopher Woods et al. · Chemical Science · 2018 · 89 citations · Full text
1–5 of 34